| Date |
Topic |
| 2008 |
| October 29 |
MedKit for the treatment or prophylaxis of pandemic influenza |
| 2007 |
| December 14 |
Effectiveness of Phenylephrine as an oral nasal decongestant |
| December 13 |
Rx-to- OTC Switch of Mevacor (lovastatin) for cholesterol reduction |
| October 18-19 |
Pediatric Use of Cold and Cough Products |
| 2006 |
| September 25 |
Actual use and label comprehension studies |
| January 24 |
Epinephrine products containing CFCs |
| January 23 |
Rx-to-OTC switch of Orlistat (tetrahydrolipstatin) for weight loss |
| 2005 |
| March 24 |
Topical corticosteriods: safety studies needed for Rx-to-OTC switch |
| March 23 |
Healthcare antiseptics: testing method |
| January 13 - 14 |
Rx-to-OTC switch of Mevacor (lovastatin) for cholesterol reduction |
| 2004 |
| May 6 - 7 |
Athlete’s foot: efficacy & labeling of antifungals |
| 2003 |
| December 16 |
Rx-to-OTC switch of Plan B (levonorgestrel) for emergency contraception |
| December 8 |
Aspirin: primary prevention of myocardial infarction |
| June 12 |
OTC status of ipecac syrup for emergency poison treatment |
| 2002 |
| September 19 - 20 |
Internal Analgesics: organ-specific warnings |
| June 21 |
Rx-to-OTC switch of Prilosec (omeprazole) for heartburn relief |
| April 22 |
Rx-to-OTC switch of Claritin (loratadine) for relief of allergic rhinitis |
| 2001 |
| May 11 |
Rx-to-OTC switch of fexofenadine, loratadine, & cetrizine for relief of allergic rhinitis |
| 2000 |
| October 20 |
Rx-to-OTC switch of Prilosec (omeprazole) for heartburn relief |
| October 19 |
Phenylpropanolamine (PPA) safety |
| July 14 |
Rx-to-OTC switch of Pravachol (pravastatin) for cholesterol reduction |
| July 13 |
Rx-to-OTC switch of Mevacor (lovastatin) for cholesterol reduction |
| July 12 |
Remarketing & labeling of Today Sponge as vaginal contraceptive |
| 1999 |
| July 20 |
Rx-to-OTC switch of Flexeril (cyclobenzaprine) for muscle pain relief |
| 1998 |
| December 2 - 3 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| December 1 |
Rx-to-OTC switch of Denavir (herpes labilis) |
| October 22 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| September 11 |
Class labeling for vaginal antifungals |
| July 29 |
Final formulation testing for healthcare antiseptics |
| July 28 |
Class labeling for vaginal antifungals |
| May 27 - 29 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| 1997 |
| October 29 - 30 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| September 18 |
Pediatric analgesic/antipyretic dosing and labeling |
| July 16 |
Rx-to-OTC switch of Rogaine (minoxidil) as hair growth stimulant |
| July 15 |
Rx-to-OTC switch of Excedrin Extra Strength (acetaminophen, aspirin, caffeine) for migraine relief |
| July 14 |
Drug Facts labeling |
May 13  |
Rx-to-OTC switch of Questran (cholesyramine resin) and Questran Light for cholesterol reduction |
| May 8-9 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| April 15 |
Vaginal douching safety |
| January 23 |
Aspirin professional labeling |
| January 22 |
Healthcare continuum model for regulation of healthcare antiseptic drug products |
| 1996 |
| November 22 |
Clinical efficacy studies for vaginal spermicides |
| November 21 |
Vaginal products to prevent HIV transmission |
| November 20 |
Antimicrobial topical vaginal agents for STD prevention |
| October 10 |
Rx-to-OTC switch of Nasalcrom (cromolyn sodium) for allergic rhinitis relief |
| October 9 |
Rx-to-OTC switch of S+ Ibuprofen (dexibuprofen) as analgesic/antipyretic |
| September 19 - 20 |
Photochemistry and Photobiology of Sunscreens (Public Meeting) |
| June 7 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| June 6 |
Alcohol content of oral healthcare mouthwashes |
| April 19 |
Rx-to-OTC switch of Nicotrol (nicotine transdermal system) for smoking cessation |
| 1995 |
| December 4 - 5 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| November 17 |
Rx-to-OTC switch of Rogaine (minoxidil) as hair growth stimulant |
| November 16 |
Common cold indication (focus on clemastine fumarate) |
| September 29 |
OTC drug labeling (discussion of Public Hearing) |
| September 28 |
Rx-to-OTC switch of Nicorette (nicotine polacrilex); nizatidine |
| September 27 |
Rx-to-OTC switch of Questran (cholestyramine) for cholesterol reduction |
| August 14 - 15 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| April 10 - 12 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| March 28 |
Motrin: pediatric use OTC muscle relaxant |
| March 27 |
Rx-to-OTC switch of Tagamet (cimetidine) for heartburn relief |
| January 13 |
Pediatric dosing of OTC drug products |
| January 12 |
Rx-to-OTC switch of Zovirax (acyclovir) to treat genital herpes |
| January 11 |
Closed meeting |
| 1994 |
| December 5 - 7 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| November 16 |
Antibiotic resistance of topical erythromycin to treat acne |
| November 14 |
OTC status of antiasthmatic drugs |
| October 11 - 12 |
Antiplaque/antigingivitis active ingredients (Panel meeting) |
| September 8 - 9 |
OTC analgesics: efficacy testing & labeling |
| July 29 |
Rx-to-OTC switch of Pepcid (famotidine) for relief of episodic heartburn |
| July 27 |
Rx-to-OTC switch of Rogaine (minoxidil) |
| May 19 |
Rx-to-OTC switch of acyclovir for management of recurrent genital herpes (Part 15 hearing) |
| 1993 |
| September 8 |
Alcohol and OTC internal analgesic medications (other than acetaminophen) |
| June 29 |
Alcohol and acetaminophen: liver toxicity |
| June 28 |
Labeling of doxylamine succinate regarding tumor development in animals; Advertising of OTC drugs by FTC |
| June 2 |
Closed meeting |
| June 1 |
Juvenile rheumatoid arthritis guidelines; Rx-to-OTC switch of Naprosyn (naproxen) |
| April 9 |
Antidiarrheal drugs containing attapulgite, kaolin, pectin |
| April 8 |
Role and appropriate doses of caffeine as an adjuvant in internal analgesic drug products |
| 1992 |
| December 17 |
Benefits and risks of alcohol in oral OTC drug products |
| December 16 |
Role of NDAC in the regulation of nonprescription products |
